Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: Pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition-Reference-Cited by-同舟云学术

Discovery of novel somatostatin receptor subtype 5 (SSTR5) antagonists: Pharmacological studies and design to improve pharmacokinetic profiles and human Ether-a-go-go-related gene (hERG) inhibition

Published:2017-08 Issue:15 Volume:25 Page:4153-4162
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Yamasaki Takeshi,Hirose Hideki,Yamashita Tohru,Takakura Nobuyuki,Morimoto Sachie,Nakahata Takashi,Kina Asato,Nakano Yoshihide,Okano Tamura Yumiko,Sugama Jun,Odani Tomoyuki,Shimizu Yuji,Iwasaki Shinji,Watanabe Masanori,Maekawa Tsuyoshi,Kasai Shizuo

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference45 articles.

1. Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

2. Somatostatin: the neuroendocrine story

3. Molecular mechanisms of somatostatin receptor trafficking;Csaba;J Mol Endocrinol,2012

4. Somatostatin-28 regulates GLP-1 secretion via somatostatin receptor subtype 5 in rat intestinal cultures

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and exploration of novel somatostatin receptor subtype 5 (SSTR5) antagonists for the treatment of cholesterol gallstones;European Journal of Medicinal Chemistry;2024-01

2. Selective somatostatin receptor 5 inhibition improves hepatic insulin sensitivity;Pharmacology Research & Perspectives;2022-12-30

3. Synthesis and Reactivity of 3‐Halo‐4,5‐dihydroisoxazoles: An Overview;ChemistrySelect;2021-08-23

4. Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity;Journal of Chemical Information and Modeling;2019-02-04

5. Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists;ACS Medicinal Chemistry Letters;2018-10-05